These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 6251398

  • 21. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M, Malaise EP.
    Sem Hop; ; 56(21-24):1094-107. PubMed ID: 6156491
    [Abstract] [Full Text] [Related]

  • 22. Lung tumorigenic response of strain A mice exposed to hypoxic cell sensitizers alone and in combination with gamma-radiation.
    Mian TA, Theiss JC, Grdina DJ.
    Cancer Res; 1983 Jan; 43(1):146-9. PubMed ID: 6847763
    [Abstract] [Full Text] [Related]

  • 23. Sensitizers and protectors in radiotherapy.
    Brown JM.
    Cancer; 1985 May 01; 55(9 Suppl):2222-8. PubMed ID: 2983876
    [Abstract] [Full Text] [Related]

  • 24. Adjuvant therapy in the treatment of malignant glioma.
    Kim RY, Langford KH, Roth RE.
    J Med Assoc State Ala; 1977 Oct 01; 47(4):39-41. PubMed ID: 200689
    [No Abstract] [Full Text] [Related]

  • 25. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
    Onoyama Y, Nakajima T, Tanaka M.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):894-903. PubMed ID: 3963856
    [Abstract] [Full Text] [Related]

  • 26. Hypoxic cell radiosensitizers in the treatment of high grade gliomas: a new direction using combined Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Newman HF, Bleehen NM, Ward R, Workman P.
    Int J Radiat Oncol Biol Phys; 1988 Sep 01; 15(3):677-84. PubMed ID: 2843488
    [Abstract] [Full Text] [Related]

  • 27. Current Landscape and Future Prospects of Radiation Sensitizers for Malignant Brain Tumors: A Systematic Review.
    Beg U, Snyder BM, Madhani SI, Hamidi N, Padmanaban V, Tuanquin LC, Kruser TJ, Connor J, Mansouri A.
    World Neurosurg; 2021 Jul 01; 151():e839-e856. PubMed ID: 33974987
    [Abstract] [Full Text] [Related]

  • 28. Misonidazole and irradiation in the treatment of high-grade astrocytomas: further report of the Vienna Study Group.
    Stadler B, Kärcher KH, Kogelnik HD, Szepesi T.
    Int J Radiat Oncol Biol Phys; 1984 Sep 01; 10(9):1713-7. PubMed ID: 6090368
    [Abstract] [Full Text] [Related]

  • 29. [Radiosensitization of hypoxic tumor cells with special reference to head and neck cancers].
    Kogelnik HD.
    Wien Klin Wochenschr; 1983 Aug 05; 95(15):515-8. PubMed ID: 6636784
    [Abstract] [Full Text] [Related]

  • 30. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M, Malaise EP.
    Pathol Biol (Paris); 1980 Jan 05; 28(1):29-42. PubMed ID: 6153787
    [Abstract] [Full Text] [Related]

  • 31. [Present status of hypoxic cell sensitizers and PLDR inhibitors].
    Ono K, Sasai K, Shibamoto Y, Tsutsui K, Fushiki M, Nishidai T, Takahashi M, Abe M.
    Gan No Rinsho; 1987 Oct 05; 33(13):1673-8. PubMed ID: 2961900
    [Abstract] [Full Text] [Related]

  • 32. [Clinical trials of hypoxic cell sensitizer misonidazole].
    Onoyama Y.
    Gan No Rinsho; 1983 May 05; 29(6):718-25. PubMed ID: 6348345
    [Abstract] [Full Text] [Related]

  • 33. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
    Moldenhauer H, Rose H, Saul G, Wolf G, Kehrberg G.
    Radiobiol Radiother (Berl); 1983 May 05; 24(5):597-614. PubMed ID: 6316407
    [No Abstract] [Full Text] [Related]

  • 34. Development and testing of new hypoxic cell radiosensitizers.
    Kimler BF, McDonald T, Cheng CC, Podrebarac EG, Mansfield CM.
    Radiology; 1979 Nov 05; 133(2):515-7. PubMed ID: 493545
    [Abstract] [Full Text] [Related]

  • 35. Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide.
    Sheehan J, Cifarelli CP, Dassoulas K, Olson C, Rainey J, Han S.
    J Neurosurg; 2010 Aug 05; 113(2):234-9. PubMed ID: 20001586
    [Abstract] [Full Text] [Related]

  • 36. Nitroimidazoles as hypoxic cell radiosensitizers and hypoxia probes: misonidazole, myths and mistakes.
    Wardman P.
    Br J Radiol; 2019 Jan 05; 92(1093):20170915. PubMed ID: 29303355
    [Abstract] [Full Text] [Related]

  • 37. Radiation therapy of rat brain tumor using misonidazole as hypoxic cell sensitizer.
    Tamura M, Inoue H, Murata M, Koizumi H, Nakamura M, Yonome I, Niibe H.
    J Cancer Res Clin Oncol; 1985 Jan 05; 109(3):188-92. PubMed ID: 4008513
    [Abstract] [Full Text] [Related]

  • 38. An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
    Shibamoto Y, Ono K, Takahashi M, Kano E, Hori H, Shibata T, Inayama S, Abe M.
    Jpn J Cancer Res; 1986 Oct 05; 77(10):1027-33. PubMed ID: 3096918
    [Abstract] [Full Text] [Related]

  • 39. Platinum complexes with one radiosensitizing ligand [PtCl2(NH3) (sensitizer)]: radiosensitization and toxicity studies in vitro.
    Skov KA, Farrell NP, Adomat H.
    Radiat Res; 1987 Nov 05; 112(2):273-82. PubMed ID: 3685256
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.